Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
Bryzgalova G, Effendic S, Khan A, Rehnmark S, Barbounis P, Boulet J, Dong G, Singh R, Shapses S, Malm J, Webb P, Baxter JD, Grover GJ.
Bryzgalova G, et al. Among authors: grover gj.
J Steroid Biochem Mol Biol. 2008 Sep;111(3-5):262-7. doi: 10.1016/j.jsbmb.2008.06.010. Epub 2008 Jun 22.
J Steroid Biochem Mol Biol. 2008.
PMID: 18621127